CPRX
NASDAQ · Biotechnology
Catalyst Pharmaceuticals Inc
$23.32
+0.53 (+2.33%)
Performance
1D
—
1W
—
1M
—
3M
-4.23%
6M
+19.47%
1Y
-9.33%
YTD
+0.73%
Open$23.06
Previous Close$22.79
Day High$23.71
Day Low$23.06
52W High$26.58
52W Low$19.05
Volume—
Avg Volume1.53M
Market Cap2.97B
P/E Ratio13.86
EPS$1.68
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$23.76
Below
SMA 200
$22.30
Above
RSI (14)
48.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
+115.0% upside
Current
$23.32
$23.32
Target
$50.13
$50.13
$36.48
$50.13 avg
$69.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 572.52M | 408.65M | 680.16M |
| Net Income | 208.34M | 133.84M | -27,885,830 |
| Profit Margin | 36.4% | 34.6% | -4.1% |
| EBITDA | 287.96M | 195.26M | -33,860,903 |
| Free Cash Flow | — | — | -33,852,425 |
| Rev Growth | +40.1% | +40.1% | +20.9% |
| Debt/Equity | — | — | 0.20 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |